Skip to main content

Journals in Pharmaceutical sciences

Elsevier's Pharmaceutical Sciences collection helps pharmaceutical scientists striving to optimize drug design and improve healthcare outcomes by offering comprehensive coverage of every aspect of drug development, integrating disciplines like organic chemistry, biology, and biotechnology. Focused on safety, efficacy, and formulation design, it includes specialized fields such as Clinical Pharmacology and Translational Research, providing valuable insights into the latest advancements in drug discovery.

  • American Journal of Pharmaceutical Education

    • ISSN: 0002-9459
    The Official Journal of the American Association of Colleges of Pharmacy (AACP)The American Journal of Pharmaceutical Education is an official scholarly publication of the American Association of Colleges of Pharmacy (AACP). Its purpose is to document and advance pharmaceutical education in the United States and internationally.
  • Drug Metabolism and Pharmacokinetics

    • ISSN: 1347-4367
    Official Online Journal of the Japanese Society for the Study of Xenobiotics and the International Society for the Study of XenobioticsDrug Metabolism and Pharmacokinetics (DMPK) is an official online journal of the Japanese Society for the Study of Xenobiotics (JSSX) and the International Society for the Study of Xenobiotics (ISSX), and it replaces the JSSX's former journal, Xenobiotic Metabolism and Disposition. The journal will accept original submissions in English on the understanding that the work is unpublished and is not being considered for publication elsewhere.Scope of submitted manuscripts DMPK publishes original and innovative scientific papers that address topics broadly related to xenobiotics. The term xenobiotic includes medicinal as well as environmental and agricultural chemicals and macromolecules. The journal is organized into sections as follows: - Drug metabolism / Biotransformation - Pharmacokinetics and pharmacodynamics - Toxicokinetics and toxicodynamics - Drug-drug interaction / Drug-food interaction - Mechanism of drug absorption and disposition (including transporter) - Drug delivery system - Clinical pharmacy and pharmacology - Analytical method - Factors affecting drug metabolism and transport - Expression of genes for drug-metabolizing enzymes and transporters - Pharmacogenetics and pharmacogenomics - Pharmacoepidemiology
  • Currents in Pharmacy Teaching and Learning

    • ISSN: 1877-1297
    Currents in Pharmacy Teaching and Learning is devoted to dissemination of high quality, peer-reviewed scholarship relevant to all areas of pharmacy education—promoting educational research excellence. The Journal maintains a particular focus in two major areas: pharmacy faculty development in the scholarship of teaching and learning and the scholarship of interprofessional pharmacy education. With diverse editorial board members, authors, and peer reviewers, the Journal engages a variety of stakeholders in pharmacy education: educators, researchers, faculty practitioners, as well as interprofessional colleagues. Diverse author contributions are within original research, review articles, commentaries, and letters categories.Original research topics include, but are not limited to:Scholarship of Teaching and Learning: teaching/learning strategies; interprofessional educationQuality Improvement - assessment of programmatic/curricu... outcomesCurricular Revision – design, implementation, evaluationNew school/program strategiesAttitudes/... within pharmacy education
  • Journal of Controlled Release

    • ISSN: 0168-3659
    The Journal of Controlled Release (JCR) is the Official Journal of the Controlled Release Society, and of the Japan Society of Drug Delivery System.It publishes high-quality research articles in the broad field of delivery science and technology. This includes drug delivery systems and all aspects of formulations, such as physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development in the disciplines of pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries.Manuscrip... that advance fundamental understanding of principles and/or demonstrate advantages of novel technologies in safety and efficacy over current clinical standards will be given priority.
  • Journal of Pharmaceutical and Biomedical Analysis

    • ISSN: 0731-7085
    This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome.Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradant... dealing with the analytical aspects of traditional folk medicines are acceptable if the results are expected to attract the interest of readers also outside the area of origin, i.e. they have a focus on innovative analytical approaches. Regional differences in the phytochemical content of traditional folk medicine will not be considered. Manuscripts reporting on the analysis of novel phytochemicals will only be considered if their biological activity has been previously published in an international medium. Pharmacokinetic studies of traditional folk medicine will only be considered if only the identified components have been demonstrated to be solely responsible for the pharmacological activity.Bioanalytic... papers (pharmacokinetic, bioequivalence, protein and DNA binding studies) are accepted if the focus is on innovative analytical methodology. Manuscripts describing the pharmacokinetic profile of a single compound will not be considered for review. Pharmacokinetic studies will only be considered if they offer new profiles of a drug(s) and its metabolite(s) or new understandings of the mechanisms in drug disposition or response of existing drugs. Analytical studies on new investigational drugs that are currently in the preclinical phase are only acceptable if their pharmacological activity is well documented in an international medium.Human subjects research must provide ethical approval and should include the name of the approving committee and the name of the institution and reference number where approval was granted. Animal studies must be approved from their Institutions Animal Care and Use Committee or any equivalent ethics committee accompanied by the reference number. For blood sampling procedures in rodents, retro-orbital bleeding will only be considered if a minimum of 7 days is allowed between repeat sampling. Furthermore, in the evaluation of the manuscript the editors reserve the right to determine whether the animal experimental technique is appropriate.In determining the suitability of submitted articles for publication, particular scrutiny will be placed on the degree of novelty and significance of the research and the extent to which it adds to existing knowledge in pharmaceutical and biomedical analysis. In all submissions to the journal, authors must address the question of how their proposed methodology compares with previously reported methods. A substantial body of work cannot be fractionated into different shorter papers.
  • International Journal of Pharmaceutics

    • ISSN: 0378-5173
    The International Journal of Pharmaceutics is the third most cited journal in the "Pharmacy & Pharmacology" category out of 366 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.Editorial Policy The over-riding criteria for publication are originality, high scientific quality and interest to a multidisciplinary audience. Papers not sufficiently substantiated by experimental detail will not be published. Any technical queries will be referred back to the author, although the Editors reserve the right to make alterations in the text without altering the technical content. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur with the submission and that a copy of the final manuscript has been approved by all authors and tacitly or explicitly by the responsible authorities in the laboratories where the work was carried out. If accepted, the manuscript shall not be published elsewhere in the same form, in either the same or another language, without the consent of the Editors and Publisher.Authors must state in a covering letter when submitting papers for publication the novelty embodied in their work or in the approach taken in their research. Routine bioequivalence studies are unlikely to find favour. No paper will be published which does not disclose fully the nature of the formulation used or details of materials which are key to the performance of a product, drug or excipient. Work which is predictable in outcome, for example the inclusion of another drug in a cyclodextrin to yield enhanced dissolution, will not be published unless it provides new insight into fundamental principles.
  • European Journal of Pharmaceutics and Biopharmaceutics

    • ISSN: 0939-6411
    Official journal of the International Association for Pharmaceutical TechnologyThe European Journal of Pharmaceutics and Biopharmaceutics provides a medium for the publication of novel, innovative and hypothesis-driven research from the areas of Pharmaceutics and Biopharmaceutics.Top... covered include for example:Design and development of drug delivery systems for pharmaceuticals and biopharmaceuticals (small molecules, proteins, nucleic acids)Aspects of manufacturing process designBiomedical aspects of drug product designStrategies and formulations for controlled drug transport across biological barriersPhysicochemi... aspects of drug product developmentNovel excipients for drug product designDrug delivery and controlled release systems for systemic and local applicationsNanomate... for therapeutic and diagnostic purposesAdvanced therapy medicinal productsMedical devices supporting a distinct pharmacological effect"The Rules of 3"The Editors and Editorial board have developed the "Rules of 3". Authors must consider the following three criteria before they submit a manuscript and set the whole process of editing and reviewing at work: The paper must report on novel findings that are not merely an unprecedented combination of known aspects in pharmaceutics and biopharmaceutics of major importance. The paper must be based on a thorough and extensive study, using established or well-described methods and including proper controls. Research must be hypothesis-driven and conclusions must be supported by the data presented.The study described in the manuscript must not merely confirm the state of the art in the field of pharmaceutics and biopharmaceutics, but advance it.
  • Drug Resistance Updates

    • ISSN: 1368-7646
    Drug Resistance Updates publishes inspiring original research, commentary and expert reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance. It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology, and clinical medicine. The Editors welcome and encourage the submission of original research articles while review articles are written by leaders in the field of drug resistance by invitation.
  • Next Research

    • ISSN: 3050-4759
    Next Research is a peer-reviewed multidisciplinary journal, publishing research spanning all scientific technical and medical communities.The journal is part of the Next family, a new suite of multidisciplinary journals from Elsevier spanning all branches of science. Managed by our dedicated team of in-house Editors, Next Research offers authors speed, consistency, innovation, flexibility, and ease of submission.Next Research is an inclusive venue for scientifically accurate manuscripts that meet the ethical and scientific publishing standards. It publishes all research topics across the fields of health sciences, physical sciences, life sciences and social sciences. Next Research publishes experimental, computational, and theoretical work, in traditional formats such as Original Research Articles, Communications and Reviews, as well as novel formats and video content.The journal provides authors with rigorous peer review ensuring articles adhere to a high technical standard, with rapid decisions and a highly visible platform for scientists to share their research.We believe that all rigorous research should be shared.
  • Journal of Clinical Epidemiology

    • ISSN: 0895-4356
    Metascience and innovative methods to improve population healthThe Journal of Clinical Epidemiology (JCE) aims to advance science that can improve health care decision-making and contribute to the evolving discipline of clinical epidemiology. The JCE publishes methods-focused articles across the spectrum of the research ecosystem, including primary research (qualitative, quantitative, and mixed); evidence syntheses; guidelines; and implementation science. The journal welcomes registered reports, protocols, and simulation studies that advance the journal’s aims. The JCE promotes inclusive research and health equity and is committed to ensuring a diversity of perspectives across its content, contributors, editorial board, and leadership.The journal publishes topics including:Meta-scien... researchDevelopment, evaluation, and implementation of reporting guidelines Research integrity and cultureOpen scienceEmerging methodologies Developing and evaluating outcome measuresEducation and learning programs for clinical epidemiologistThe JCE does not accept the following submissions except in exceptional circumstances: Bibliometric studies and those on infodemiology, social media trends, and health informaticsPapers written primarily for a statistical audience Artificial intelligence and machine learning studies without critical evaluation of the method and transparent reportingMeta-resear... studies that demonstrate weaknesses or limitations in the evidence ecosystem but lack reflection on how these might be addressedEffectivene... studies, including Mendelian randomization studies and target trial emulations; systematic reviews; prevalence and incidence studies; prognostic or diagnostic research where the main focus is not on the methodsStudies limited to one country, jurisdiction, or clinical area with limited generalizability, such as: translating an outcome measure into a different language; a study focused on one clinical specialty; a Delphi/consensus-bas... study where all the authors are from one country; or a survey of participants from one setting or with a limited response rateStudies with a single author where it was more appropriate for a multi-disciplinary team to conduct the researchStudies that do not include patient partners as members of the research team in circumstances where that would be considered essentialAnimal studies Pharmacovigilance and pharmacoepidemiology studies